Fund profile
Lugano Ventures
United States
Not leading
About
Lugano Ventures is an investment firm that focuses on early-stage companies in high-tech and life science industries. Founded by Fred Seddiqui, who has over 30 years of executive management experience, the firm leverages his extensive background in both high-tech and life sciences to drive growth and value creation in its portfolio companies. Some notable exits from his previous ventures include AFx Inc., acquired by Boston Scientific, and Vivant Medical Technologies, acquired by Covidien. The investment strategy of Lugano Ventures centers on identifying promising startups and supporting them through strategic partnerships and executive leadership. The firm's current team includes experts like Dr. Jacques Van Dam, a renowned professor of medicine and clinical scholar, and Kristen McEntyre, co-founder and president of Tutti Dynamics. Lugano Ventures primarily invests in technology and media enterprises, with a strong focus on companies that offer innovative service propositions and have the potential for high growth. They have a track record of working with companies across various stages, providing not just capital but also strategic guidance to help them achieve their ambitious goals.
Details
Showing 0 lists
Contacts
Website
luganoventures.comLists that include this fund